CICC Research Begins Coverage on Intuitive Surgical (NASDAQ:ISRG)

Equities research analysts at CICC Research initiated coverage on shares of Intuitive Surgical (NASDAQ:ISRG) in a note issued to investors on Monday. The firm set a “neutral” rating and a $550.00 price target on the medical equipment provider’s stock. CICC Research’s price objective would indicate a potential downside of 4.29% from the company’s previous close.

Other equities research analysts have also recently issued reports about the stock. Jefferies Financial Group upped their price target on shares of Intuitive Surgical from $475.00 to $575.00 in a report on Monday. Evercore ISI upped their price target on shares of Intuitive Surgical from $490.00 to $530.00 in a report on Monday. Royal Bank of Canada increased their target price on shares of Intuitive Surgical from $611.00 to $641.00 in a research note on Monday. Mizuho increased their target price on shares of Intuitive Surgical from $440.00 to $500.00 in a research note on Thursday, October 17th. Finally, Oppenheimer reiterated a “market perform” rating on shares of Intuitive Surgical in a research note on Friday, October 18th. One investment analyst has rated the stock with a sell rating, five have issued a hold rating and sixteen have issued a buy rating to the stock. According to data from MarketBeat, the stock presently has an average rating of “Moderate Buy” and a consensus target price of $610.95.

Intuitive Surgical Trading Down 1.6 %

Intuitive Surgical stock traded down $9.41 during mid-day trading on Monday, hitting $574.65. 1,391,095 shares of the company’s stock were exchanged, compared to its average volume of 1,954,819. Intuitive Surgical has a 1-year low of $364.17 and a 1-year high of $616.00. The stock has a 50 day moving average of $547.16 and a two-hundred day moving average of $505.21. The stock has a market cap of $204.68 billion, a P/E ratio of 92.27, a P/E/G ratio of 5.19 and a beta of 1.39.

Insider Activity at Intuitive Surgical

In other Intuitive Surgical news, CEO Gary S. Guthart sold 18,151 shares of Intuitive Surgical stock in a transaction on Wednesday, October 30th. The shares were sold at an average price of $511.63, for a total transaction of $9,286,596.13. Following the completion of the sale, the chief executive officer now owns 24,219 shares of the company’s stock, valued at approximately $12,391,166.97. The trade was a 42.84 % decrease in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through the SEC website. Also, insider Jamie Samath sold 22,903 shares of Intuitive Surgical stock in a transaction on Friday, November 8th. The stock was sold at an average price of $525.00, for a total transaction of $12,024,075.00. Following the sale, the insider now directly owns 8,757 shares of the company’s stock, valued at $4,597,425. This represents a 72.34 % decrease in their position. The disclosure for this sale can be found here. Insiders sold a total of 42,453 shares of company stock valued at $22,059,506 over the last quarter. Corporate insiders own 0.90% of the company’s stock.

Institutional Trading of Intuitive Surgical

Institutional investors have recently bought and sold shares of the business. Berbice Capital Management LLC bought a new position in shares of Intuitive Surgical during the fourth quarter worth $26,000. Godsey & Gibb Inc. boosted its position in shares of Intuitive Surgical by 140.0% during the third quarter. Godsey & Gibb Inc. now owns 60 shares of the medical equipment provider’s stock worth $29,000 after purchasing an additional 35 shares in the last quarter. MidAtlantic Capital Management Inc. bought a new position in shares of Intuitive Surgical during the third quarter worth $33,000. Decker Retirement Planning Inc. bought a new position in shares of Intuitive Surgical during the fourth quarter worth $36,000. Finally, Capital Performance Advisors LLP bought a new position in shares of Intuitive Surgical during the third quarter worth $38,000. Institutional investors and hedge funds own 83.64% of the company’s stock.

Intuitive Surgical Company Profile

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.